Niraparib-induced STAT3 inhibition increases its antitumor effects.
Zhao Q, Kohut A, Li YJ, Martincuks A, Austria T, Zhang C, Santiago NL, Borrero RM, Phan XT, Melstrom L, Rodriguez-Rodriguez L, Yu H.
Zhao Q, et al.
Front Oncol. 2022 Oct 17;12:966492. doi: 10.3389/fonc.2022.966492. eCollection 2022.
Front Oncol. 2022.
PMID: 36324587
Free PMC article.